Kristin L M Boylan

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. pmc Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation
    Kristin L M Boylan
    Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA E Mails K L M B B M M S D J D A K M H S E P
    Int J Mol Sci 12:1334-58. 2011
  2. pmc Quantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum
    Kristin Lm Boylan
    Department of Laboratory Medicine and Pathology, University of Minnesota, MMC 609, 420 Delaware St, SE, Minneapolis, MN, USA
    Proteome Sci 8:31. 2010
  3. pmc Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
    John D Andersen
    Department of Laboratory Medicine and Pathology, University of Minnesota, MMC 609, 420 Delaware St, SE Minneapolis, MN, USA
    J Ovarian Res 3:21. 2010
  4. pmc S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival
    Melissa S DeRycke
    Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, USA
    Am J Clin Pathol 132:846-56. 2009
  5. pmc Isothermal vitrification methodology development for non-cryogenic storage of archival human sera
    Rebekah Less
    Biostabilization Laboratory, Department of Mechanical Engineering, University of Minnesota, 111 Church St SE, Minneapolis, MN 55455, USA
    Cryobiology 66:176-85. 2013
  6. pmc Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis
    John D Andersen
    Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA
    Electrophoresis 31:599-610. 2010
  7. doi request reprint Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
    Amy P N Skubitz
    Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA Electronic address
    Gynecol Oncol 130:579-87. 2013

Collaborators

  • Peter A Argenta
  • Angela Panoskaltsis-Mortari
  • C Blake Gilks
  • Alptekin Aksan
  • Amy P N Skubitz
  • John D Andersen
  • Rebekah Less
  • Bruce A Witthuhn
  • Katherine M Harrington
  • Melissa S DeRycke
  • Daniel A Vallera
  • Nate N Waldron
  • Seunguk Oh
  • Elizabeth P Taras
  • Todd W Markowski
  • Lorraine B Anderson
  • Starchild Weivoda
  • Ronald Jemmerson
  • Benjamin Misemer
  • Feifei S Xue
  • Amy Pn Skubitz
  • Melissa A Geller
  • Rachel Isaksson Vogel
  • LeeAnn Higgins
  • Stefan E Pambuccian
  • Steve E Kalloger

Detail Information

Publications7

  1. pmc Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation
    Kristin L M Boylan
    Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA E Mails K L M B B M M S D J D A K M H S E P
    Int J Mol Sci 12:1334-58. 2011
    ..The inability of the NIH:OVCAR5 cells treated with claudin 4 shRNA to form compact spheroids was verified by FITC-dextran exclusion. These results demonstrate a role for claudin 4 and tight junctions in spheroid formation and integrity...
  2. pmc Quantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum
    Kristin Lm Boylan
    Department of Laboratory Medicine and Pathology, University of Minnesota, MMC 609, 420 Delaware St, SE, Minneapolis, MN, USA
    Proteome Sci 8:31. 2010
    ..In this study, we used pooled serum depleted of the most highly abundant proteins to reduce the dynamic range of proteins, and thereby enhance the identification of serum biomarkers using the quantitative proteomic method iTRAQ(R)...
  3. pmc Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
    John D Andersen
    Department of Laboratory Medicine and Pathology, University of Minnesota, MMC 609, 420 Delaware St, SE Minneapolis, MN, USA
    J Ovarian Res 3:21. 2010
    ..We previously demonstrated the upregulation of leucine-rich alpha-2-glycoprotein-1 (LRG1) in the sera of ovarian cancer patients compared to healthy women using quantitative mass spectrometry...
  4. pmc S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival
    Melissa S DeRycke
    Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, USA
    Am J Clin Pathol 132:846-56. 2009
    ..In the endometrioid subtype of ovarian and endometrial cancers, relapse-free survival was decreased for patients with S100A1+ tumors. These data suggest that S100A1 is a marker for poor prognosis of endometrioid subtypes of cancer...
  5. pmc Isothermal vitrification methodology development for non-cryogenic storage of archival human sera
    Rebekah Less
    Biostabilization Laboratory, Department of Mechanical Engineering, University of Minnesota, 111 Church St SE, Minneapolis, MN 55455, USA
    Cryobiology 66:176-85. 2013
    ..These results demonstrated the feasibility of long-term storage of vitrified serum at hypothermic (and non-cryogenic) temperatures...
  6. pmc Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis
    John D Andersen
    Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA
    Electrophoresis 31:599-610. 2010
    ..Western blotting validated the relative increases in serum protein levels for three of the proteins identified, demonstrating the utility of this approach for the identification of novel serum biomarkers for ovarian cancer...
  7. doi request reprint Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
    Amy P N Skubitz
    Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA Electronic address
    Gynecol Oncol 130:579-87. 2013
    ..The hypothesis driving this study is that despite their low numbers in ovarian cancer tumors, CSC can be eradicated using CD133 targeted therapy and tumor growth can be inhibited...